| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.071 | 0.6 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.16 | 0.6 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.065 | 0.6 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |